Skip to content

Michael Bloch



Bloch Michael
Michael Bloch



Michael has extensive experience in a wide range of corporate finance and equity capital markets transactions, including IPOs, rights issues, placings, block trades and other secondary offerings, as well as public and private acquisitions and disposals, frequently on a cross-border basis.

He specialises in advising listed companies, investment banks, shareholders and private equity sponsors on complex equity financing and underwriting structures, public and private mergers and acquisitions, the rules and market practice relating to primary and secondary equity offerings and major transactions for listed companies, and other corporate governance and advisory matters.

In addition, he acts for growth companies and start-ups raising equity through private funding rounds and on acquisitions, with a particular focus on the life sciences and technology sectors. He has spent time in Dubai working for another international law firm, as well as on secondment in the UK downstream team at ExxonMobil and in the ECM business team at Credit Suisse.

Other noteworthy experience includes advising:

  • Kuwait Energy on its USD650m acquisition by United Energy Group by way of scheme of arrangement.
  • McCarthy & Stone on its GBP388m IPO on the premium main market of the London Stock Exchange (issuer's counsel)
  • Tullet Prebon on its reverse takeover acquisition of the global hybrid voice-broking and information business of ICAP plc.
  • Cobham on its GBP500m and GBP512m rights issues on the London Stock Exchange (issuer's counsel)
  • Equinity on its GBP317m IPO on the premium main market of the London Stock Exchange (underwriters counsel)
  • Circassia Pharmaceuticals ont its GBP580m IPO on the premium main market of the London Stock Exchange and GBP275m placing and open offer in connection with the acquisitions of Aerocrine and Prosonix (issuer's counsel).
  • Softcat on its GBP153m IPO on the premium main market of the London Stock Exchange (underwriter's counsel)
  • Spire Healthcare on its GBP842m IPO on the premium main market of the London Stock Exchange (underwriter's counsel)
  • Sensyne Health a digital healthcare company that develops regulated medical products and services using artificial intelligence, on its GBP225m IPO on the London Stock Exchange's AIM market.
  • Medopad on its Series A funding round to develop its healthcare technology data-capture platform.

News & insights

LCD panel of lights

News: 22 MARCH 2020

Allen & Overy advises JP Morgan on EUR 300 million high yield bond offering for Sazka Group

Allen & Overy announced that it represented J.P. Morgan, HSBC, Société Générale, UniCredit, Erste Group, and J&T BANKA as initial purchasers on the issuance of EUR300mn 3.875% Senior Notes due 2027 by SAZKA Group. The transaction followed a successful entry by SAZKA Group of international capital markets in November 2019, when the company issued its first high yield bond worth EUR300mn, bearing a fixed coupon of 4.125% due in 2024. 

Read more

Publications: 16 MARCH 2020

Coronavirus - what is the current situation in Germany?

In order to contain the Coronavirus the German federal states as well as the German government have put strict measures into place. Schools and kindergartens have been closed as well as borders to most neighbouring states for private travel. In order to mitigate the economic consequences, the German government announced a comprehensive package of measures.

Read more

Publications: 11 MARCH 2020

FCA proposes enhanced climate-related financial disclosure for companies with listed equity

New Listing Rules applicable to premium listed commercial companies.

Read more

Publications: 23 JANUARY 2020

Equity capital markets: navigating the challenges of 2020

2019 was a challenging year for equity capital markets. Proceeds from IPOs fell by over 25% in the UK, and by more than 30% across Europe. A number of political and economic factors, which contributed to pricing uncertainty and market volatility, undoubtedly led to this reduction in activity. 

Read more



Allen & Overy LLP
One Bishops Square
E1 6AD

View office →



Admitted as solicitor, England and Wales, 2006


MA (Oxon), History, University of Oxford, 2002

Dip. Law, Nottingham Law School, 2003

LPC, Nottingham Law School, 2004

Experience highlights